RecruitMe Clinical Trial

Multi-Site Trial of Combined Pharmacotherapy to Treat Cocaine Dependence
A study of two medications together to treat cocaine dependence
Sponsor:National Institute on Drug Abuse
Enrolling:Male and Female Patients
Study Length:14 Weeks
Clinic Visits:42
Age Range:Between 18 and 60 years old
IRB Number:6698
U.S. Government ID:NCT01811940
Contact: Daniel Brooks: 212-923-3031 / brooksd@nyspi.columbia.edu
Additional Study Information:

The study is a two group outpatient study, one group receiving medications (Adderall-XR and topiramate) and one group receiving a placebo (inactive sugar pill). The study is looking at the safety and effectiveness of Adderall-XR (MAS-ER) and topiramate in the treatment of cocaine dependence. It is a 14-week trial that requires patients to attend visits 3 times per week.

This study is closed
Investigator
Frances Levin, MD
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:

Daniel Brooks

brooksd@nyspi.columbia.edu

212-923-3031

YesYesYes3